Cargando…

Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning

BACKGROUND: Human immunodeficiency virus (HIV) and methamphetamine use commonly affect neurocognitive (NC) functioning. We evaluated the relationships between NC functioning and two fibroblast growth factors (FGFs) in volunteers who differed in HIV serostatus and methamphetamine dependence (MAD). ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bharti, Ajay R, Woods, Steven Paul, Ellis, Ronald J, Cherner, Mariana, Rosario, Debra, Potter, Michael, Heaton, Robert K, Everall, Ian P, Masliah, Eliezer, Grant, Igor, Letendre, Scott L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857802/ https://www.ncbi.nlm.nih.gov/pubmed/27199571 http://dx.doi.org/10.2147/HIV.S93306

Ejemplares similares

The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
por: Rogers, Jeffrey M., et al.
Publicado: (2023)

Reply to Augello, P.A.; Wu, J. Comment on “Rogers et al. The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition. Viruses 2023, 15, 674”
por: Rogers, Jeffrey M., et al.
Publicado: (2023)

The Relationships between HIV-1 Infection, History of Methamphetamine Use Disorder, and Soluble Biomarkers in Blood and Cerebrospinal Fluid
por: Walter, T. Jordan, et al.
Publicado: (2021)

Epigenetic Alterations in the Brain Associated with HIV-1 Infection and Methamphetamine Dependence
por: Desplats, Paula, et al.
Publicado: (2014)

Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV
por: Saloner, Rowan, et al.
Publicado: (2022)

COMT Val158Met Polymorphism, Executive Dysfunction, and Sexual Risk Behavior in the Context of HIV Infection and Methamphetamine Dependence
por: Bousman, C. A., et al.
Publicado: (2010)

Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model
por: Saloner, Rowan, et al.
Publicado: (2021)

Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment
por: Ellis, Ronald J., et al.
Publicado: (2022)

Metabolic Syndrome and Neurocognitive Function among older Hispanics/Latinos with HIV
por: Marquine, Maria, et al.
Publicado: (2021)

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment
por: Mehta, Sanjay R., et al.
Publicado: (2017)

Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume
por: MacDuffie, Katherine E., et al.
Publicado: (2018)

Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder
por: Saloner, Rowan, et al.
Publicado: (2022)

Neurocognitive functioning in acute or early HIV infection
por: Moore, David J., et al.
Publicado: (2010)

Cerebrospinal Fluid (CSF) CD8+ T-Cells That Express Interferon-Gamma Contribute to HIV Associated Neurocognitive Disorders (HAND)
por: Schrier, Rachel D., et al.
Publicado: (2015)

Neuropsychological Test Norms for the Assessment of HIV-Associated Neurocognitive Impairment Among South African Adults
por: Deist, Melanie, et al.
Publicado: (2023)

The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV
por: Sundermann, Erin E., et al.
Publicado: (2022)

European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection
por: Samuels, David C., et al.
Publicado: (2016)

Plasma Proteomic Profiling in HIV-1 Infected Methamphetamine Abusers
por: Pottiez, Gwenael, et al.
Publicado: (2012)

Time of Day Influences Concentrations of Total Protein and Albumin in Cerebrospinal Fluid in HIV
por: Kakarla, Visesha, et al.
Publicado: (2023)

Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART
por: Oliveira, Michelli Faria de, et al.
Publicado: (2015)

Corrigendum: Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART
por: de Oliveira, Michelli Faria, et al.
Publicado: (2016)

Neurocognitive decision-making processes of casual methamphetamine users
por: Droutman, Vita, et al.
Publicado: (2018)

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
por: Edén, Arvid, et al.
Publicado: (2016)

Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood
por: Ellis, Ronald J., et al.
Publicado: (2020)

Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer
por: Fields, Jerel, et al.
Publicado: (2013)

Molecular Pathology of Neuro-AIDS (CNS-HIV)
por: Crews, Leslie, et al.
Publicado: (2009)

Apathy is associated with poorer abstinence self-efficacy in individuals with methamphetamine dependence
por: Hussain, Mariam A., et al.
Publicado: (2021)

Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years
por: Ellis, Ronald J., et al.
Publicado: (2022)

Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid
por: Grauer, Oliver M, et al.
Publicado: (2015)

Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders
por: Woods, Steven Paul, et al.
Publicado: (2009)

The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders
por: Mediouni, Sonia, et al.
Publicado: (2015)

Neurocognitive Dysfunctions and Their Therapeutic Modulation in Patients With Methamphetamine Dependence: A Pilot Study
por: Bernhardt, Nadine, et al.
Publicado: (2020)

Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals
por: Letendre, Scott L., et al.
Publicado: (2011)

Characterization of HIV-Associated Neurocognitive Impairment in Middle-Aged and Older Persons With HIV in Lima, Peru
por: Diaz, Monica M., et al.
Publicado: (2021)

“Complexity, safety and challenges: Emergency responders' experience of people affected by methamphetamines”
por: Jones, Rikki, et al.
Publicado: (2022)

The Influence of HLA on HIV-Associated Neurocognitive Impairment in Anhui, China
por: Schrier, Rachel D., et al.
Publicado: (2012)

THE CEREBROSPINAL FLUID IN SYPHILIS
por: Ellis, Arthur W. M., et al.
Publicado: (1913)

Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults
por: Patton, Stephanie M., et al.
Publicado: (2017)

Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment
por: Cassol, Edana, et al.
Publicado: (2014)

Methamphetamine augments HIV-1 gp120 inhibition of synaptic transmission and plasticity in rat hippocampal slices: Implications for methamphetamine exacerbation of HIV-associated neurocognitive disorders
por: Zheng, Ya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7nd0dr1r7non2a54m29qb4lrl7